Called sonelokimab, the product inhibits both the A and F isoforms of interleukin-17 (IL-17). In this mid-stage trial, well ...
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving ...
An 82-year-old Chinese woman was hospitalised after swallowing eight live frogs to ease her persistent lower back pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback